Agenus, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00847G7051
USD
3.07
0.03 (0.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
33.74
34.20
30.23
25.69
24.07
26.84
25.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
33.74
34.20
30.23
25.69
24.07
26.84
25.11
Raw Material Cost
0.58
0.60
3.67
3.41
3.34
3.38
3.49
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.69
16.05
13.24
13.34
12.98
20.69
35.73
Selling and Distribution Expenses
6.28
11.70
7.83
12.35
12.52
17.67
13.93
Other Expenses
-0.29
-0.85
1.04
1.34
0.85
1.31
0.53
Total Expenditure (Excl Depreciation)
18.68
19.81
35.10
42.47
37.38
54.82
58.48
Operating Profit (PBDIT) excl Other Income
15.1
14.399999999999999
-4.9
-16.8
-13.3
-28
-33.4
Other Income
40.19
17.38
-19.22
0.04
-0.08
1.28
0.02
Operating Profit (PBDIT)
55.83
32.38
-21.06
-13.57
-10.18
-23.45
-30.00
Interest
14.69
16.05
13.24
13.34
12.98
20.69
35.73
Exceptional Items
-1.35
-26.34
101.24
0.07
0.00
0.59
1.86
Gross Profit (PBDT)
33.15
33.61
26.56
22.28
20.73
23.46
21.62
Depreciation
0.58
0.60
3.03
3.17
3.20
3.26
3.35
Profit Before Tax
39.21
-10.61
63.91
-30.01
-26.37
-46.81
-67.21
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
39.23
-10.58
63.91
-27.95
-25.27
-45.86
-66.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
39.23
-10.58
63.91
-27.95
-25.27
-45.86
-66.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.02
-0.03
-0.00
-2.06
-1.10
-0.95
-0.83
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.21
-10.61
63.91
-30.01
-26.37
-46.81
-67.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
-221.22
-271.11
-274.14
-354.60
-341.85
-326.38
-292.34
Earnings per share (EPS)
1.02
-0.3
1.94
-1.0
-1.03
-2.04
-3.08
Diluted Earnings per share
1.02
-0.3
1.94
-1.0
-1.03
-2.04
-3.08
Operating Profit Margin (Excl OI)
44.62%
42.09%
-16.08%
-65.31%
-55.31%
-104.29%
-132.87%
Gross Profit Margin
117.94%
-29.28%
221.41%
-104.49%
-96.26%
-162.26%
-254.33%
PAT Margin
116.27%
-30.93%
211.39%
-108.81%
-104.99%
-170.88%
-264.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.46% vs 13.25% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 469.81% vs -116.59% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 4.00% vs 933.33% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -8.13% vs 21.21% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Agenus, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
33.74
2.40
31.34
1,305.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
33.74
2.40
31.34
1,305.83%
Raw Material Cost
0.58
0.65
-0.07
-10.77%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.69
0.00
14.69
Selling and Distribution Expenses
6.28
7.42
-1.14
-15.36%
Other Expenses
-0.29
2.06
-2.35
-114.08%
Total Expenditure (Excl Depreciation)
18.68
28.68
-10.00
-34.87%
Operating Profit (PBDIT) excl Other Income
15.05
-26.28
41.33
157.27%
Other Income
40.19
1.20
38.99
3,249.17%
Operating Profit (PBDIT)
55.83
-24.44
80.27
328.44%
Interest
14.69
0.00
14.69
Exceptional Items
-1.35
0.00
-1.35
Gross Profit (PBDT)
33.15
1.75
31.40
1,794.29%
Depreciation
0.58
0.65
-0.07
-10.77%
Profit Before Tax
39.21
-25.09
64.30
256.28%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
39.23
-25.09
64.32
256.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
39.23
-25.09
64.32
256.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.02
0.00
-0.02
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.21
-25.09
64.30
256.28%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
-221.22
102.02
-323.24
-316.84%
Earnings per share (EPS)
1.02
-0.26
1.28
492.31%
Diluted Earnings per share
1.02
-0.26
1.28
492.31%
Operating Profit Margin (Excl OI)
44.62%
-1,096.37%
0.00
1,140.99%
Gross Profit Margin
117.94%
-1,019.44%
0.00
1,137.38%
PAT Margin
116.27%
-1,046.52%
0.00
1,162.79%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3.37 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.46% vs 13.25% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 39.83% vs -13.93% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.92 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 469.81% vs -116.59% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 248.48% vs 58.43% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.56 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.00% vs 933.33% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 254.46% vs 65.76% in Mar 2025

Quarterly - Interest
Interest 1.47 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.13% vs 21.21% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 13.08% vs -55.93% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 44.62%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025